The diagram listed as Figure 2 inadvertently contained four typographical errors and should be replaced by the figure that is placed below. The number of BRCA1 carriers with prostate-specific antigen 3 ng/ml was 731 (not 732), the positive predictive value of biopsy in BRCA1 carriers was 37.5% (not 40.9%); 80.0% (not 60%) of BRCA1 controls and 70.8% (not 68%) of BRCA2 carriers had intermediate/high risk disease. These changes do not change the content (the data are correct in the text and the tables) or the conclusions of the paper.
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